ProQR Therapeutics N.V (PRQR) Return on Capital Employed: 2021-2025
Historic Return on Capital Employed for ProQR Therapeutics N.V (PRQR) over the last 4 years, with Sep 2025 value amounting to -335.70%.
- ProQR Therapeutics N.V's Return on Capital Employed fell 10576.00% to -335.70% in Q3 2025 from the same period last year, while for Sep 2025 it was -335.70%, marking a year-over-year decrease of 10576.00%. This contributed to the annual value of -0.27% for FY2024, which is 1.00% up from last year.
- Per ProQR Therapeutics N.V's latest filing, its Return on Capital Employed stood at -335.70% for Q3 2025, which was down 15.93% from -289.56% recorded in Q2 2025.
- Over the past 5 years, ProQR Therapeutics N.V's Return on Capital Employed peaked at -0.25% during Q3 2023, and registered a low of -335.70% during Q3 2025.
- In the last 3 years, ProQR Therapeutics N.V's Return on Capital Employed had a median value of -186.54% in 2024 and averaged -132.95%.
- Its Return on Capital Employed has fluctuated over the past 5 years, first rose by 27bps in 2023, then tumbled by 22,969bps in 2024.
- Quarterly analysis of 5 years shows ProQR Therapeutics N.V's Return on Capital Employed stood at -0.36% in 2021, then fell by 17bps to -0.53% in 2022, then increased by 27bps to -0.26% in 2023, then slumped by 21,763bps to -217.90% in 2024, then plummeted by 10,576bps to -335.70% in 2025.
- Its Return on Capital Employed was -335.70% in Q3 2025, compared to -289.56% in Q2 2025 and -201.17% in Q1 2025.